列纳利多米德和波马利多米德酶体与前列腺素 (PG) 蛋白的结合相互作用的计算分析:癌症炎症活性在癌症中的影响
Kalpana Tiwari1, Vikas Kumar2, Ashish Kumar3
1Pharmacology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, IND.
Cureus
|April 1, 2024
概括
列纳利多米德和波马利多米德反体强烈与Pg蛋白结合,这表明了针对癌症炎症的新策略. 这项研究探讨了它们在控制瘤内的炎症活动方面的潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算化学计算化学
- 在瘤学瘤学.
背景情况:
- 列纳利多米德和波马利多米德是具有抗血管和抗炎功能的性免疫调节药物 (IMiDs).
- 单个反体可能表现出不同的生物活性和结合特征.
- 癌症的炎症微环境在瘤进展中起着至关重要的作用.
研究的目的:
- 为了研究莱纳利多米德和波马利多米德反体与前列腺素 (Pg) 蛋白在体内结合.
- 探索这种结合对癌症持续炎症活动的潜在影响.
- 为了深入了解促炎媒介运输及其在瘤炎症微环境中的作用.
主要方法:
- 利用分子对接研究来评估结合潜力.
- 从蛋白质数据库 (PDB ID: 1IW7) 中获得了Pg蛋白的晶体结构.
主要成果:
- 这四种反体均显示出与Pg蛋白有显著的结合亲缘关系.
- 结合能量在 -6.7 到 -8.1 kcal/mol.之间.
- 在所有化合物和Pg蛋白的关键氨基酸残留物之间形成了键,距离从2.0到2.2 Å.
结论:
- 列纳利多米德和波马利多米德的两个反体都对Pg蛋白具有很高的亲和力.
- 这些药物可能会准Pg蛋白通路,以调节癌症中持续的炎症活性.
- 针对炎症介导过程提供了一种针对瘤进展的新疗法策略.
更多相关视频
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
4.2K
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
13.8K
相关概念视频
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Combined Effects of Drugs: Antagonism
8.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K
Drug-Receptor Interactions
5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
